Variant report
Variant | esv3321881 |
---|---|
Chromosome Location | chr8:121854571-121855569 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs535441098 | chr8:121854662-121854663 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs186999113 | chr8:121854670-121854671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs193177415 | chr8:121854678-121854679 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539729927 | chr8:121854688-121854689 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558013067 | chr8:121854702-121854703 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs71308613 | chr8:121854753-121854754 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573073954 | chr8:121854949-121854950 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11997119 | chr8:121854984-121854985 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs11989946 | chr8:121855049-121855050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573582560 | chr8:121855051-121855052 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543831536 | chr8:121855058-121855059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563656709 | chr8:121855060-121855061 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531145587 | chr8:121855061-121855062 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6469957 | chr8:121855078-121855079 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs188600923 | chr8:121855104-121855105 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs564388522 | chr8:121855113-121855114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6469958 | chr8:121855126-121855127 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs547272367 | chr8:121855148-121855149 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561993902 | chr8:121855169-121855170 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs193127260 | chr8:121855184-121855185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550732320 | chr8:121855253-121855254 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs535476844 | chr8:121855343-121855344 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs377617165 | chr8:121855360-121855361 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114895581 | chr8:121855389-121855390 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149994257 | chr8:121855391-121855392 | Weak transcription Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145199724 | chr8:121855419-121855420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs533699795 | chr8:121855424-121855425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs555458434 | chr8:121855437-121855438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538447080 | chr8:121855446-121855447 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573622731 | chr8:121855461-121855462 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6994902 | chr8:121855464-121855465 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs565658188 | chr8:121855477-121855478 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs375953247 | chr8:121855478-121855479 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577217371 | chr8:121855501-121855502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4621851 | chr8:121855512-121855513 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Gastric cancer | 17908304 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Testicular cancer | 18059402 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Breast cancer | 21611746 | CNVD |
Developmental delay | 21147756 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Papillary thyroid cancer | 17515504 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Breast cancer | 20932292 | CNVD |
Gastric cancer | 22539939 | CNVD |
Breast cancer | 22056952 | CNVD |
Langer-Giedion syndrome | 16773131 | CNVD |
Lung cancer | 16740712 | CNVD |
Mental retardation | 16773131 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Langer-Giedion syndrome | 22470819 | CNVD |
Cornelia de Lange syndrome | 24599119 | CNVD |
Gastric cancer | 21528007 | CNVD |
Breast cancer | 22532251 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21129771 | CNVD |
benign familial neonatal convulsions | 18472482 | CNVD |
Breast cancer | 16417655 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Breast cancer | 20814816 | CNVD |
Colorectal cancer | 22486879 | CNVD |
Breast cancer | 17908964 | CNVD |
Colorectal cancer | 20031965 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian cancer | 17908964 | CNVD |
Ovarian cancer | 20031965 | CNVD |
Prostate cancer | 20031965 | CNVD |
Non-small cell lung cancer | 17643093 | CNVD |
Prostate cancer | 19242612 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 18698023 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Uveal melanoma | 20484589 | CNVD |
head and neck squamous cell carcinoma | 16740747 | CNVD |
Breast cancer | 19181860 | CNVD |
Endometrial cancer | 23636398 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Breast cancer | 16397240 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Breast cancer | 21364760 | CNVD |
Oral squamous cell carcinoma | 21853135 | CNVD |
Cancer | 20164919 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Breast cancer | 22522925 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:121838400-121869800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr8:121850400-121855200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr8:121851800-121856800 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
4 | chr8:121851800-121857200 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr8:121852000-121858200 | Enhancers | HepG2 | liver |
6 | chr8:121852400-121856800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr8:121852800-121855200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
8 | chr8:121854200-121854600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
9 | chr8:121854400-121854600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr8:121854400-121854600 | Enhancers | Liver | Liver |
11 | chr8:121854600-121855000 | Weak transcription | Liver | Liver |
12 | chr8:121855000-121856400 | Enhancers | Liver | Liver |
13 | chr8:121855200-121855400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
14 | chr8:121855200-121855400 | Bivalent Enhancer | HUES48 Cell Line | embryonic stem cell |
15 | chr8:121855200-121855800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr8:121855200-121855800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |